◆英語タイトル:Vistin Pharma AS (VISTIN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8147
◆発行会社(調査会社):
GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Vistin Pharma AS (Vistin), a subsidiary of Vistin Pharma ASA is a healthcare company that produces and supplies active pharmaceutical ingredients and solid dosage forms. The company’s products include opioids, an analgesics and antitussive; metformin, an API for the treatment of diabetes II; and pholcodine, an antitussive. It also provides branded and patented combinations products and plain generic and branded generic metformin tablets. Vistin Pharma offers contract manufacturing for granulate and solid dosage forms and offers customer service, technical services and logistics services. The company provides its products and services to international pharmaceutical companies. It operates through a network of distributors and agents located across Africa, Europe, Asia, and the Americas. The company’s manufacturing facilities are located in Sannidal and Kragero, Norway. Vistin Pharma is headquartered in Oslo, Norway.
Vistin Pharma AS (VISTIN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vistin Pharma AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Vistin Pharma Raises USD6.2 Million in Private Placement of Shares 10
Vistin Pharma Raises USD38.8 Million in Private Placement of Shares 12
Vistin Pharma Raises USD20 Million in Rights Offering of Shares 13
Asset Transactions 14
TPI Enterprises Acquires Opioids and CMO Business from Vistin Pharma 14
Acquisition 15
Geveran Trading Divests 5.17% Stake in Vistin Pharma 15
Vistin Pharma AS – Key Competitors 16
Vistin Pharma AS – Key Employees 17
Vistin Pharma AS – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Strategy And Business Planning 19
Jan 30, 2018: Vistin Pharma ASA : Vistin Pharma to postpone the expansion of the metformin production capacity 19
Financial Announcements 20
Aug 30, 2018: Vistin Pharma announces 20 per cent revenue growth in second quarter 2018 20
Apr 26, 2018: Vistin Pharma : Delivers 22% revenue growth in first quarter 2018 21
Feb 27, 2018: Vistin Pharma : Fourth quarter 2017 results 22
Oct 27, 2017: Vistin Pharma: Third quarter 2017 results – strong growth, capacity expansion on track 23
Apr 26, 2017: Vistin Pharma: First quarter 2017 results 24
Feb 28, 2017: Vistin Pharma: Fourth quarter and preliminary 2016 results 25
Other Significant Developments 26
Aug 31, 2017: Vistin Pharma Second quarter 2017 results – continuing strong demand for metformin 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List of Tables
Vistin Pharma AS, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vistin Pharma AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vistin Pharma AS, Deals By Therapy Area, 2012 to YTD 2018 8
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vistin Pharma Raises USD6.2 Million in Private Placement of Shares 10
Vistin Pharma Raises USD38.8 Million in Private Placement of Shares 12
Vistin Pharma Raises USD20 Million in Rights Offering of Shares 13
TPI Enterprises Acquires Opioids and CMO Business from Vistin Pharma 14
Geveran Trading Divests 5.17% Stake in Vistin Pharma 15
Vistin Pharma AS, Key Competitors 16
Vistin Pharma AS, Key Employees 17
List of Figures
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8